Detalles de la búsqueda
1.
The academic point-of-care anti-CD19 chimeric antigen receptor T-cell product varnimcabtagene autoleucel (ARI-0001 cells) shows efficacy and safety in the treatment of relapsed/refractory B-cell non-Hodgkin lymphoma.
Br J Haematol;
204(2): 525-533, 2024 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-37905734
2.
Endothelial Activation and Stress Index in adults undergoing allogeneic hematopoietic cell transplantation with post-transplant cyclophosphamide-based prophylaxis.
Cytotherapy;
26(1): 73-80, 2024 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-37952139
3.
Fractionated initial infusion and booster dose of ARI0002h, a humanised, BCMA-directed CAR T-cell therapy, for patients with relapsed or refractory multiple myeloma (CARTBCMA-HCB-01): a single-arm, multicentre, academic pilot study.
Lancet Oncol;
24(8): 913-924, 2023 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-37414060
4.
Prognostic impact of MYD88 and CXCR4 mutations assessed by droplet digital polymerase chain reaction in IgM monoclonal gammopathy of undetermined significance and smouldering Waldenström macroglobulinaemia.
Br J Haematol;
200(2): 187-196, 2023 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36210485
5.
Real-world data on survival improvement in patients with multiple myeloma treated at a single institution over a 45-year period.
Br J Haematol;
196(3): 649-659, 2022 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-34622447
6.
Results of ARI-0001 CART19 cell therapy in patients with relapsed/refractory CD19-positive acute lymphoblastic leukemia with isolated extramedullary disease.
Am J Hematol;
97(6): 731-739, 2022 06 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-35253928
7.
European Myeloma Network perspective on CAR T-Cell therapies for multiple myeloma.
Haematologica;
106(8): 2054-2065, 2021 08 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-33792221
8.
Immunoparesis defined by heavy/light chain pair suppression in smoldering multiple myeloma shows initial isotype specificity and involves other isotypes in advanced disease.
Ann Hematol;
100(12): 2997-3005, 2021 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-34463804
9.
Gut Microbiota Influence in Hematological Malignancies: From Genesis to Cure.
Int J Mol Sci;
22(3)2021 Jan 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-33498529
10.
Loss of the Immune Checkpoint CD85j/LILRB1 on Malignant Plasma Cells Contributes to Immune Escape in Multiple Myeloma.
J Immunol;
200(8): 2581-2591, 2018 04 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-29531171
11.
Impact of Autologous Stem Cell Transplantation on the Incidence and Outcome of Oligoclonal Bands in Patients with Light-Chain Amyloidosis.
Biol Blood Marrow Transplant;
23(8): 1269-1275, 2017 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-28434927
12.
The evolving pattern of the monoclonal protein improves the IMWG 2/20/20 classification for patients with smoldering multiple myeloma.
Hemasphere;
8(5): e76, 2024 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-38716147
13.
Easix Score Correlates With Endothelial Dysfunction Biomarkers and Predicts Risk of Acute Graft-Versus-Host Disease After Allogeneic Transplantation.
Transplant Cell Ther;
30(2): 187.e1-187.e12, 2024 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-38000709
14.
Post-Transplantation Cyclophosphamide and Tacrolimus for Graft-versus-Host Disease Prevention after Allogeneic Hematopoietic Cell Transplantation from HLA-Matched Donors Has More Advantages Than Limitations.
Transplant Cell Ther;
30(2): 213.e1-213.e12, 2024 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-38042256
15.
EASIX and cardiac adverse events after allogeneic hematopoietic cell transplantation.
Bone Marrow Transplant;
2024 Mar 23.
Artículo
en Inglés
| MEDLINE | ID: mdl-38521885
16.
Biomarkers of Efficacy and Safety of the Academic BCMA-CART ARI0002h for the Treatment of Refractory Multiple Myeloma.
Clin Cancer Res;
30(10): 2085-2096, 2024 May 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-38466644
17.
Outcomes of Patients with Newly Diagnosed Transplant-Ineligible Multiple Myeloma According to Clinical Trials Enrollment: Experience of a Single Institution.
Cancers (Basel);
15(21)2023 Nov 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-37958434
18.
Applicability and validation of different prognostic scores in allogeneic hematopoietic cell transplant (HCT) in the post-transplant cyclophosphamide era.
Hematol Transfus Cell Ther;
2023 Oct 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-37891074
19.
Effect of CD34+ Cell Dose on the Outcomes of Allogeneic Stem Cell Transplantation with Post-Transplantation Cyclophosphamide.
Transplant Cell Ther;
29(3): 181.e1-181.e10, 2023 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-36526259
20.
At-Home Foscarnet Administration in Patients with Cytomegalovirus Infection Post-Allogeneic Stem Cell Transplantation: A Unicentric, Safe, and Feasible Program.
Pharmaceuticals (Basel);
16(12)2023 Dec 18.
Artículo
en Inglés
| MEDLINE | ID: mdl-38139867